Market Overview

Research and Markets: Frontiers in Anti-infective Drug Discovery Volume 1


Research and Markets ( has announced the addition of the "Frontiers in Anti-infective Drug Discovery Volume 1" book to their offering.

Frontiers in Anti-Infective Drug Discovery is an Ebook series devoted to publishing the latest and the most important advances in Anti-Infective drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Infective drug design and discovery. Each volume is devoted to the major advances in Anti-Infective drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Key Topics Covered:

Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases

Light Activated Compounds as Patented Antimicrobial Agents

Proteases and Kinases: Attractive Targets for Combating Infectious Diseases

Antibacterial Therapy in the Elderly

SARS Coronavirus Anti-Infectives

Probiotics as Drugs Against Human Gastrointestinal Pathogens

Insights into the Treatment of Helicobacter pylori Infection

Inhibitors of Bacterial Efflux Pumps as Adjuvants in Antibacterial Therapy and Diagnostic Tools for Detection of Resistance by Efflux

Drugs Candidates in Advanced Clinical Trials Against Tuberculosis

Drug Effects on Drug Targets: Inhibition of Enzymes by Neuroleptics, Antimycotics, Antibiotics and Other Drugs on Human Pathogenic Amoebas and their Anti-Proliferative Effects

Macrophage Inflammatory Protein 1 and CCR5 as Potential Therapeutic Targets for HIV Infection and Acquired Immunodeficiency Syndrome

Small-Molecule Inhibitors of Raf for Treatment of Malignant Diseases

Tigecycline: A New Treatment Choice Against Acinetobacter baumannii

Cefepime and its Role in Pediatric Infections

Antibacterial Properties of Organosulfur Anti-Infectives: A Review of Patent Literature 1999-2009

A Review of the Carbapenems in Clinical Use and Clinical Trials

Anti-Infective Quinone Derivatives of Recent Patents

Targets and Patented Drugs for Chemotherapy of Chagas Disease

Recent Patents on Development of Nucleic Acid-Based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections

For more information visit

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Discovery

View Comments and Join the Discussion!

Partner Center